Literature DB >> 1594625

Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome.

W F Schwindinger1, C A Francomano, M A Levine.   

Abstract

McCune-Albright syndrome (MAS) is characterized by polyostotic fibrous dysplasia, café-au-lait lesions, and a variety of endocrine disorders, including precocious puberty, hyperthyroidism, hypercortisolism, growth hormone excess, and hyperprolactinemia. The diverse metabolic abnormalities seen in MAS share the involvement of cells that respond to extracellular signals through activation of the hormone-sensitive adenylyl cyclase system (EC 4.6.1.1). Mutations that lead to constitutive activation of Gs alpha, the guanine nucleotide-binding regulatory protein that stimulates adenylyl cyclase activity, have been identified in a subset of human growth hormone-secreting pituitary tumors and human thyroid tumors. We report here the identification of a mutation in the gene encoding Gs alpha in a patient with MAS. Denaturing gradient gel electrophoresis was used to analyze amplified DNA fragments including exon 8 or exon 9 of the Gs alpha gene. In one subject with MAS a G-to-A transition was found in exon 8 of one of the two alleles encoding Gs alpha. This single-base substitution results in the replacement of arginine by histidine at position 201 of the mature Gs alpha protein. Semiquantitative analysis of amplified DNA indicated that the mutant allele was less prevalent than the wild-type allele in peripheral leukocytes and was present in very low levels in skin. These findings support the previous contention that the segmental distribution and variable expression of the cutaneous, skeletal, and endocrine manifestations of MAS reflect an underlying somatic mosaicism. Further, these results suggest that the molecular basis of MAS is a postzygotic mutation in Gs alpha that causes constitutive activation of adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1594625      PMCID: PMC49247          DOI: 10.1073/pnas.89.11.5152

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy.

Authors:  J L Patten; D R Johns; D Valle; C Eil; P A Gruppuso; G Steele; P M Smallwood; M A Levine
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

2.  Two G protein oncogenes in human endocrine tumors.

Authors:  J Lyons; C A Landis; G Harsh; L Vallar; K Grünewald; H Feichtinger; Q Y Duh; O H Clark; E Kawasaki; H R Bourne
Journal:  Science       Date:  1990-08-10       Impact factor: 47.728

3.  G proteins and dual control of adenylate cyclase.

Authors:  A G Gilman
Journal:  Cell       Date:  1984-03       Impact factor: 41.582

4.  Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein.

Authors:  M A Levine; R W Downs; A M Moses; N A Breslau; S J Marx; R D Lasker; R E Rizzoli; G D Aurbach; A M Spiegel
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

5.  Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.

Authors:  S J Marx; A M Spiegel; E M Brown; R Windeck; D G Gardner; R W Downs; M Attie; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1978-12       Impact factor: 5.958

6.  Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome.

Authors:  C M Foster; J L Ross; T Shawker; O H Pescovitz; D L Loriaux; G B Cutler; F Comite
Journal:  J Clin Endocrinol Metab       Date:  1984-06       Impact factor: 5.958

7.  The McCune-Albright syndrome.

Authors:  N Mauras; R M Blizzard
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1986

8.  Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.

Authors:  L Cuttler; J A Jackson; M Saeed uz-Zafar; L L Levitsky; R C Mellinger; L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1989-06       Impact factor: 5.958

9.  Hypomelanosis of Ito--a nonspecific marker of somatic mosaicism: report of case with trisomy 18 mosaicism.

Authors:  D Chitayat; J M Friedman; M M Johnston
Journal:  Am J Med Genet       Date:  1990-03

10.  The McCune-Albright syndrome: a lethal gene surviving by mosaicism.

Authors:  R Happle
Journal:  Clin Genet       Date:  1986-04       Impact factor: 4.438

View more
  113 in total

Review 1.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues.

Authors:  A Sakamoto; Y Oda; Y Iwamoto; M Tsuneyoshi
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

3.  Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.

Authors:  T Yamamoto; K Ozono; S Kasayama; K Yoh; K Hiroshima; M Takagi; S Matsumoto; T Michigami; K Yamaoka; T Kishimoto; S Okada
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 4.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

5.  Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess.

Authors:  Alison M Boyce; McKinley Glover; Marilyn H Kelly; Beth A Brillante; John A Butman; Edmond J Fitzgibbon; Carmen C Brewer; Christopher K Zalewski; Carolee M Cutler Peck; H Jeffrey Kim; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2012-10-23       Impact factor: 5.958

6.  Genetic diagnosis of multiple affected tissues in a patient with McCune-Albright syndrome.

Authors:  Ji Zhou; Li-hao Sun; Bin Cui; Huai-dong Song; Xiao-ying Li; Guang Ning; Jian-min Liu
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

Review 7.  Clinical use of the long acting somatostatin analogue octreotide in pediatrics.

Authors:  M T Tauber; A G Harris; P Rochiccioli
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

8.  Severe arterial hypertension: a possible complication of McCune-Albright syndrome.

Authors:  Yasuhisa Ohata; Takehisa Yamamoto; Ikuko Mori; Toru Kikuchi; Toshimi Michigami; Yasuo Imanishi; Kenichi Satomura; Shinobu Ida; Keiichi Ozono
Journal:  Eur J Pediatr       Date:  2008-10-29       Impact factor: 3.183

Review 9.  Fibrous dysplasia and fibroblast growth factor-23 regulation.

Authors:  Alison M Boyce; Nisan Bhattacharyya; Michael T Collins
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

10.  FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.

Authors:  Jyothsna Gattineni; Carlton Bates; Katherine Twombley; Vangipuram Dwarakanath; Michael L Robinson; Regina Goetz; Moosa Mohammadi; Michel Baum
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.